PLAY PODCASTS
Decera Clinical Education Oncology Podcast

Decera Clinical Education Oncology Podcast

Decera Clinical Education

265 episodesEN

Show overview

Decera Clinical Education Oncology Podcast has been publishing since 2020, and across the 6 years since has built a catalogue of 265 episodes. That works out to roughly 110 hours of audio in total. Releases follow a weekly cadence.

Episodes typically run twenty to thirty-five minutes — most land between 16 min and 30 min — though episode length varies meaningfully from one episode to the next. It is catalogued as a EN-language Education show.

The show is actively publishing — the most recent episode landed 3 days ago, with 42 episodes already out so far this year. The busiest year was 2021, with 69 episodes published. Published by Decera Clinical Education.

Episodes
265
Running
2020–2026 · 6y
Median length
22 min
Cadence
Weekly

From the publisher

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Latest Episodes

View all 265 episodes

Experts Discuss Health Disparities and Equitable Care Strategies in Multiple Myeloma

Aug 20, 202613 min

Experts Discuss CELMoD Agents for Multiple Myeloma

Aug 20, 202626 min

Optimizing Oral Targeted Therapies for HR+/HER2- Breast Cancer

Aug 14, 202632 min

TGCT Today: Understanding Diagnosis, Treatment, and Long-term Care

Aug 13, 202636 min

Optimizing Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Pharmacist Perspectives

Aug 12, 202628 min

New and Emerging Targeted Therapies for Patients With DLBCL

Aug 7, 202638 min

Changing the Paradigm in HER2-Positive Early Breast Cancer

Aug 7, 202625 min

Recent Advances, Future Directions, and Ideas on Integrating CELMoDs Into The Care Of Patients With Myeloma

Aug 3, 202617 min

To Treat or Not to Treat: Assessing Risk and Treatment Options in High-Risk SMM

Jul 29, 202648 min

Unmet Needs, Recent Advances, and Expert Insights on Integrating TROP-2 ADCs Into the Care of Patients With TNBC

Jul 28, 202622 min

Optimizing Bispecific Antibody Safety and Care Coordination From the Pharmacy in RRMM

Jul 23, 202630 min

Targeting the Future of Pancreatic Cancer Care: RAS, Biomarkers, and Emerging Therapies

Jul 22, 202628 min

Beyond BCMA: How GPRC5D-Targeted Therapy Fits into Multiple Myeloma Care Today

Jul 14, 202626 min

What Oncology Pharmacists Need to Know About Targeting BCMA in Early Relapsed/Refractory Myeloma

Jul 13, 202628 min

Incorporating AKT1 and PIK3CA Pathway Testing and Targeted Therapies in the Management of Advanced Endocrine-Resistant Breast Cancer

Jun 30, 202624 min

Personalizing EGFR Mutation–Positive NSCLC Care: Strategies for the Advanced Practice Provider

Jun 22, 202626 min

Advancing the Early Detection of Lung Cancer: Expanding Screening Access, Eligibility, and Awareness

Jun 9, 202627 min

HNSCC: Current and Emerging Therapeutic Strategies

May 29, 202626 min

Navigating Relapsed/Refractory Multiple Myeloma: Real-world Use of Bispecific Antibodies

May 15, 202620 min

Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma

May 7, 202631 min
2020 Decera Clinical Education Oncology Podcast